Send the following on WhatsApp
Continue to ChatCOSMIC-311 clinical trial : Exelixis enrolls patients to study cabozantinib in phase 3 thyroid cancer trial https://business-news-today.com/cosmic-311-clinical-trial-exelixis-enrolls-patients-to-study-cabozantinib-in-phase-3-thyroid-cancer-trial-2/